Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Primary Health Care | 45 | 2024 | 4638 | 3.690 |
Why?
|
Patient-Centered Care | 16 | 2021 | 1414 | 1.550 |
Why?
|
Quality of Health Care | 20 | 2021 | 4356 | 1.310 |
Why?
|
Comprehensive Health Care | 3 | 2017 | 124 | 1.250 |
Why?
|
Delivery of Health Care | 13 | 2021 | 5310 | 0.950 |
Why?
|
Physicians, Primary Care | 10 | 2021 | 623 | 0.930 |
Why?
|
Developing Countries | 12 | 2021 | 2862 | 0.900 |
Why?
|
Reimbursement, Incentive | 6 | 2020 | 543 | 0.860 |
Why?
|
Organizational Innovation | 4 | 2018 | 535 | 0.770 |
Why?
|
Rheumatology | 5 | 2018 | 611 | 0.690 |
Why?
|
Fee-for-Service Plans | 7 | 2019 | 705 | 0.680 |
Why?
|
Tobacco Use Disorder | 7 | 2015 | 699 | 0.620 |
Why?
|
Practice Management | 1 | 2017 | 37 | 0.580 |
Why?
|
Physician Assistants | 3 | 2015 | 187 | 0.560 |
Why?
|
Quality Improvement | 9 | 2021 | 3835 | 0.560 |
Why?
|
Early Detection of Cancer | 9 | 2021 | 3203 | 0.540 |
Why?
|
Nurse Practitioners | 3 | 2015 | 268 | 0.530 |
Why?
|
Health Services Accessibility | 8 | 2020 | 5366 | 0.520 |
Why?
|
Arthritis, Rheumatoid | 8 | 2019 | 3772 | 0.510 |
Why?
|
Review Literature as Topic | 1 | 2017 | 339 | 0.490 |
Why?
|
Chronic Disease | 8 | 2017 | 9245 | 0.480 |
Why?
|
Tobacco Industry | 6 | 2011 | 135 | 0.480 |
Why?
|
Specialization | 2 | 2018 | 780 | 0.480 |
Why?
|
Health Care Surveys | 8 | 2019 | 2434 | 0.460 |
Why?
|
Risk Management | 1 | 2017 | 559 | 0.450 |
Why?
|
Developed Countries | 1 | 2016 | 439 | 0.450 |
Why?
|
Physicians | 4 | 2022 | 4583 | 0.450 |
Why?
|
Models, Educational | 2 | 2017 | 372 | 0.420 |
Why?
|
American Recovery and Reinvestment Act | 1 | 2012 | 72 | 0.400 |
Why?
|
Office Visits | 3 | 2015 | 596 | 0.400 |
Why?
|
Medicare | 6 | 2021 | 6763 | 0.400 |
Why?
|
Schools, Public Health | 1 | 2011 | 22 | 0.400 |
Why?
|
Ghana | 4 | 2020 | 311 | 0.390 |
Why?
|
Academic Medical Centers | 3 | 2020 | 2750 | 0.380 |
Why?
|
Health Facilities | 3 | 2022 | 576 | 0.380 |
Why?
|
Motivation | 2 | 2020 | 1991 | 0.380 |
Why?
|
Health Promotion | 3 | 2014 | 2204 | 0.370 |
Why?
|
Medical Informatics | 3 | 2012 | 732 | 0.360 |
Why?
|
Health Care Reform | 6 | 2020 | 1245 | 0.360 |
Why?
|
United States | 39 | 2024 | 72238 | 0.360 |
Why?
|
Electronic Health Records | 5 | 2018 | 4737 | 0.360 |
Why?
|
Reimbursement Mechanisms | 4 | 2020 | 662 | 0.350 |
Why?
|
Public Health Practice | 1 | 2011 | 218 | 0.330 |
Why?
|
Medication Adherence | 3 | 2018 | 2161 | 0.320 |
Why?
|
Osteogenesis Imperfecta | 1 | 2009 | 81 | 0.320 |
Why?
|
Health Plan Implementation | 2 | 2013 | 335 | 0.310 |
Why?
|
Decision Support Systems, Clinical | 3 | 2016 | 1161 | 0.310 |
Why?
|
Health Policy | 5 | 2017 | 2674 | 0.300 |
Why?
|
International Cooperation | 3 | 2013 | 1435 | 0.300 |
Why?
|
Patient Care Team | 8 | 2017 | 2509 | 0.300 |
Why?
|
Smoking Cessation | 5 | 2013 | 2059 | 0.290 |
Why?
|
Antirheumatic Agents | 4 | 2019 | 1375 | 0.290 |
Why?
|
Smoking | 6 | 2011 | 9066 | 0.290 |
Why?
|
Humans | 103 | 2024 | 759098 | 0.290 |
Why?
|
Education, Medical, Graduate | 2 | 2022 | 2352 | 0.290 |
Why?
|
Bezoars | 1 | 2007 | 29 | 0.280 |
Why?
|
Public Policy | 1 | 2011 | 560 | 0.280 |
Why?
|
Quality Assurance, Health Care | 3 | 2017 | 2179 | 0.270 |
Why?
|
Cost of Illness | 3 | 2013 | 1937 | 0.270 |
Why?
|
Faculty, Medical | 1 | 2014 | 1185 | 0.270 |
Why?
|
Noonan Syndrome | 1 | 2007 | 120 | 0.270 |
Why?
|
Collagen Type I | 1 | 2009 | 615 | 0.260 |
Why?
|
Colorectal Neoplasms | 3 | 2017 | 6853 | 0.260 |
Why?
|
Internship and Residency | 3 | 2022 | 5860 | 0.260 |
Why?
|
Bone Diseases, Metabolic | 1 | 2009 | 409 | 0.250 |
Why?
|
Population Surveillance | 2 | 2019 | 2610 | 0.250 |
Why?
|
Poverty | 1 | 2016 | 2679 | 0.240 |
Why?
|
Costa Rica | 3 | 2021 | 177 | 0.230 |
Why?
|
Program Development | 4 | 2017 | 1295 | 0.230 |
Why?
|
Health Services Research | 4 | 2019 | 1809 | 0.230 |
Why?
|
Organizational Case Studies | 2 | 2017 | 301 | 0.230 |
Why?
|
Gaucher Disease | 1 | 2004 | 110 | 0.230 |
Why?
|
Anger | 1 | 2006 | 401 | 0.220 |
Why?
|
Costs and Cost Analysis | 3 | 2019 | 1674 | 0.220 |
Why?
|
Cross-Sectional Studies | 18 | 2022 | 25853 | 0.220 |
Why?
|
Medical Indigency | 1 | 2003 | 63 | 0.220 |
Why?
|
Life Expectancy | 2 | 2021 | 1248 | 0.210 |
Why?
|
Mass Screening | 2 | 2017 | 5419 | 0.210 |
Why?
|
National Health Insurance, United States | 1 | 2003 | 100 | 0.210 |
Why?
|
Health Status | 2 | 2020 | 4079 | 0.210 |
Why?
|
Genes, p53 | 1 | 2005 | 714 | 0.210 |
Why?
|
Health Expenditures | 5 | 2020 | 2354 | 0.210 |
Why?
|
Medicine | 1 | 2011 | 943 | 0.200 |
Why?
|
Research Design | 2 | 2017 | 6165 | 0.200 |
Why?
|
Massachusetts | 7 | 2018 | 8788 | 0.190 |
Why?
|
Drugs, Essential | 1 | 2022 | 70 | 0.190 |
Why?
|
Models, Organizational | 2 | 2015 | 546 | 0.190 |
Why?
|
Directive Counseling | 2 | 2013 | 170 | 0.180 |
Why?
|
Intestine, Small | 1 | 2007 | 1204 | 0.180 |
Why?
|
Leadership | 3 | 2021 | 1368 | 0.180 |
Why?
|
Clinical Competence | 2 | 2017 | 4775 | 0.170 |
Why?
|
Gatekeeping | 1 | 2018 | 49 | 0.160 |
Why?
|
Phagocytosis | 1 | 2004 | 1535 | 0.160 |
Why?
|
Preferred Provider Organizations | 1 | 2018 | 38 | 0.160 |
Why?
|
Male | 37 | 2021 | 358602 | 0.160 |
Why?
|
Practice Guidelines as Topic | 6 | 2017 | 7460 | 0.160 |
Why?
|
Rural Health Services | 2 | 2019 | 381 | 0.160 |
Why?
|
Community Health Services | 2 | 2015 | 653 | 0.160 |
Why?
|
Attitude of Health Personnel | 3 | 2017 | 3864 | 0.160 |
Why?
|
Middle Aged | 30 | 2020 | 219628 | 0.160 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2018 | 87 | 0.150 |
Why?
|
Program Evaluation | 2 | 2018 | 2487 | 0.150 |
Why?
|
Female | 39 | 2021 | 390174 | 0.150 |
Why?
|
Quality Indicators, Health Care | 3 | 2017 | 1822 | 0.140 |
Why?
|
Capitation Fee | 1 | 2017 | 116 | 0.140 |
Why?
|
Insurance Carriers | 1 | 2019 | 156 | 0.140 |
Why?
|
Adult | 31 | 2021 | 219353 | 0.140 |
Why?
|
Self Report | 3 | 2020 | 3699 | 0.140 |
Why?
|
Factor Analysis, Statistical | 1 | 2019 | 998 | 0.140 |
Why?
|
Health Care Costs | 5 | 2017 | 3253 | 0.140 |
Why?
|
Family Planning Services | 1 | 2019 | 264 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 611 | 0.130 |
Why?
|
Continuity of Patient Care | 3 | 2017 | 1060 | 0.130 |
Why?
|
Guideline Adherence | 3 | 2018 | 2283 | 0.130 |
Why?
|
Mammography | 2 | 2017 | 2449 | 0.130 |
Why?
|
Health Maintenance Organizations | 1 | 2018 | 659 | 0.130 |
Why?
|
Gift Giving | 1 | 2016 | 76 | 0.130 |
Why?
|
Documentation | 2 | 2020 | 885 | 0.130 |
Why?
|
Life Style | 2 | 2010 | 3886 | 0.130 |
Why?
|
Reminder Systems | 2 | 2016 | 387 | 0.130 |
Why?
|
Capacity Building | 1 | 2018 | 257 | 0.130 |
Why?
|
Stress, Psychological | 2 | 2013 | 4429 | 0.130 |
Why?
|
Public Sector | 1 | 2017 | 265 | 0.130 |
Why?
|
Health Surveys | 3 | 2017 | 4059 | 0.130 |
Why?
|
Erythrocytes | 1 | 2004 | 2416 | 0.120 |
Why?
|
Staff Development | 1 | 2017 | 230 | 0.120 |
Why?
|
Ambulatory Care | 3 | 2021 | 2775 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3152 | 0.120 |
Why?
|
Patient Satisfaction | 2 | 2020 | 3448 | 0.120 |
Why?
|
Evidence-Based Medicine | 2 | 2021 | 3694 | 0.120 |
Why?
|
Aftercare | 1 | 2021 | 919 | 0.120 |
Why?
|
Physician Incentive Plans | 1 | 2016 | 165 | 0.120 |
Why?
|
Aged | 21 | 2021 | 168615 | 0.120 |
Why?
|
Community Mental Health Services | 1 | 2017 | 392 | 0.120 |
Why?
|
Health Personnel | 4 | 2021 | 3308 | 0.110 |
Why?
|
Cooperative Behavior | 3 | 2017 | 1501 | 0.110 |
Why?
|
Private Sector | 1 | 2017 | 398 | 0.110 |
Why?
|
Patient Transfer | 1 | 2021 | 775 | 0.110 |
Why?
|
National Health Programs | 1 | 2017 | 442 | 0.110 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2016 | 2016 | 0.110 |
Why?
|
Qualitative Research | 3 | 2021 | 2939 | 0.110 |
Why?
|
Chi-Square Distribution | 2 | 2019 | 3469 | 0.110 |
Why?
|
Practice Management, Medical | 1 | 2015 | 191 | 0.110 |
Why?
|
Coronary Artery Disease | 1 | 2013 | 6643 | 0.110 |
Why?
|
Health Resources | 1 | 2019 | 927 | 0.110 |
Why?
|
Nurse's Role | 1 | 2014 | 188 | 0.110 |
Why?
|
Pandemics | 3 | 2024 | 8604 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2017 | 933 | 0.100 |
Why?
|
Outpatients | 1 | 2020 | 1601 | 0.100 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2013 | 166 | 0.100 |
Why?
|
Patient Care Planning | 1 | 2017 | 907 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 1783 | 0.100 |
Why?
|
Renal Replacement Therapy | 1 | 2013 | 272 | 0.090 |
Why?
|
Long-Term Care | 1 | 2015 | 627 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1395 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2015 | 498 | 0.090 |
Why?
|
Adolescent | 10 | 2020 | 87551 | 0.090 |
Why?
|
Cotinine | 1 | 2011 | 203 | 0.090 |
Why?
|
Young Adult | 9 | 2020 | 58477 | 0.090 |
Why?
|
Socioeconomic Factors | 7 | 2019 | 7790 | 0.090 |
Why?
|
Disease Management | 3 | 2016 | 2495 | 0.090 |
Why?
|
Blood Pressure | 1 | 2006 | 8520 | 0.090 |
Why?
|
Psychometrics | 1 | 2019 | 3046 | 0.090 |
Why?
|
Pilot Projects | 3 | 2014 | 8530 | 0.090 |
Why?
|
Remission Induction | 1 | 2015 | 2388 | 0.090 |
Why?
|
Insurance Coverage | 2 | 2021 | 1939 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2913 | 0.080 |
Why?
|
Linear Models | 2 | 2017 | 5876 | 0.080 |
Why?
|
Procollagen | 1 | 2009 | 188 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2017 | 21019 | 0.080 |
Why?
|
Health Records, Personal | 1 | 2010 | 126 | 0.080 |
Why?
|
Republic of Korea | 2 | 2021 | 566 | 0.080 |
Why?
|
Comprehension | 1 | 2014 | 613 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 3960 | 0.080 |
Why?
|
Career Choice | 1 | 2014 | 755 | 0.080 |
Why?
|
Schools, Medical | 1 | 2014 | 877 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15815 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2013 | 1253 | 0.070 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2009 | 265 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1882 | 0.070 |
Why?
|
Epidemiologic Research Design | 1 | 2010 | 367 | 0.070 |
Why?
|
Cost Savings | 1 | 2012 | 921 | 0.070 |
Why?
|
Samoa | 1 | 2006 | 5 | 0.070 |
Why?
|
Government Regulation | 1 | 2011 | 526 | 0.070 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2010 | 786 | 0.070 |
Why?
|
Models, Theoretical | 3 | 2015 | 3556 | 0.070 |
Why?
|
Humeral Fractures | 1 | 2009 | 282 | 0.070 |
Why?
|
Education | 1 | 2009 | 534 | 0.060 |
Why?
|
Hypertension | 4 | 2016 | 8582 | 0.060 |
Why?
|
Health Behavior | 1 | 2017 | 2619 | 0.060 |
Why?
|
Lobbying | 1 | 2005 | 32 | 0.060 |
Why?
|
Income | 4 | 2017 | 1876 | 0.060 |
Why?
|
Time Factors | 4 | 2019 | 40083 | 0.060 |
Why?
|
South Africa | 1 | 2011 | 1810 | 0.060 |
Why?
|
Haiti | 2 | 2018 | 549 | 0.060 |
Why?
|
Physician's Role | 1 | 2012 | 920 | 0.060 |
Why?
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2005 | 4 | 0.060 |
Why?
|
Medical History Taking | 1 | 2009 | 773 | 0.060 |
Why?
|
Forecasting | 1 | 2014 | 2928 | 0.060 |
Why?
|
Patient Participation | 1 | 2014 | 1437 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2500 | 0.060 |
Why?
|
Mutation | 2 | 2009 | 29878 | 0.060 |
Why?
|
Professional Practice | 2 | 2017 | 313 | 0.060 |
Why?
|
Politics | 1 | 2011 | 815 | 0.060 |
Why?
|
Histiocytes | 1 | 2004 | 98 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2010 | 15726 | 0.060 |
Why?
|
Scientific Misconduct | 1 | 2005 | 74 | 0.060 |
Why?
|
History, 21st Century | 1 | 2010 | 1574 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2018 | 58864 | 0.060 |
Why?
|
Mental Health Services | 1 | 2015 | 1708 | 0.060 |
Why?
|
Odds Ratio | 1 | 2015 | 9712 | 0.050 |
Why?
|
Conflict of Interest | 2 | 2005 | 548 | 0.050 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1725 | 0.050 |
Why?
|
Physical Examination | 1 | 2009 | 1243 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2013 | 2062 | 0.050 |
Why?
|
Carcinogens | 1 | 2005 | 449 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2019 | 80125 | 0.050 |
Why?
|
History, 20th Century | 1 | 2010 | 2775 | 0.050 |
Why?
|
Models, Economic | 2 | 2017 | 717 | 0.050 |
Why?
|
Patient Preference | 2 | 2020 | 919 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20027 | 0.050 |
Why?
|
European Union | 1 | 2002 | 156 | 0.050 |
Why?
|
Risk Factors | 6 | 2013 | 74167 | 0.050 |
Why?
|
Curriculum | 1 | 2014 | 3710 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2438 | 0.050 |
Why?
|
Age Factors | 5 | 2017 | 18391 | 0.050 |
Why?
|
Aspirin | 1 | 2013 | 3359 | 0.050 |
Why?
|
Intercostal Muscles | 1 | 2000 | 26 | 0.050 |
Why?
|
New Zealand | 1 | 2021 | 354 | 0.050 |
Why?
|
Singapore | 1 | 2021 | 287 | 0.040 |
Why?
|
Medicaid | 1 | 2014 | 2808 | 0.040 |
Why?
|
Disease Outbreaks | 1 | 2010 | 1757 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2005 | 13243 | 0.040 |
Why?
|
Local Government | 1 | 2020 | 80 | 0.040 |
Why?
|
Public Health | 2 | 2024 | 2656 | 0.040 |
Why?
|
Research Personnel | 1 | 2005 | 582 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2013 | 3193 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2012 | 3598 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2005 | 1333 | 0.040 |
Why?
|
Medication Reconciliation | 1 | 2021 | 151 | 0.040 |
Why?
|
Fibroblasts | 1 | 2009 | 4085 | 0.040 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2005 | 1987 | 0.040 |
Why?
|
Tuberculosis | 1 | 2011 | 2002 | 0.040 |
Why?
|
Testosterone | 1 | 2009 | 2468 | 0.040 |
Why?
|
Internet | 1 | 2010 | 3073 | 0.040 |
Why?
|
Rhode Island | 1 | 2019 | 350 | 0.040 |
Why?
|
Hypoglycemia | 1 | 2005 | 883 | 0.040 |
Why?
|
Hospitals, Community | 1 | 2020 | 367 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3329 | 0.040 |
Why?
|
Risk Assessment | 3 | 2019 | 24049 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 7788 | 0.040 |
Why?
|
Health Systems Plans | 1 | 2017 | 19 | 0.040 |
Why?
|
Germ Cells | 1 | 2021 | 635 | 0.040 |
Why?
|
Models, Econometric | 1 | 2017 | 216 | 0.040 |
Why?
|
Uganda | 1 | 2022 | 1326 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2013 | 3364 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2021 | 1574 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2005 | 818 | 0.040 |
Why?
|
Urban Health Services | 1 | 2017 | 177 | 0.030 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 165 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2024 | 1394 | 0.030 |
Why?
|
Poverty Areas | 1 | 2017 | 264 | 0.030 |
Why?
|
Cohort Studies | 3 | 2017 | 41266 | 0.030 |
Why?
|
Skin | 1 | 2009 | 4466 | 0.030 |
Why?
|
Serotonin | 1 | 2000 | 1034 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6788 | 0.030 |
Why?
|
Coronary Disease | 1 | 2010 | 5989 | 0.030 |
Why?
|
Online Systems | 1 | 2016 | 181 | 0.030 |
Why?
|
Motor Neurons | 1 | 2000 | 864 | 0.030 |
Why?
|
Prevalence | 4 | 2013 | 15639 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 64867 | 0.030 |
Why?
|
Oklahoma | 1 | 2014 | 36 | 0.030 |
Why?
|
Community Health Centers | 1 | 2017 | 452 | 0.030 |
Why?
|
Social Responsibility | 1 | 2017 | 384 | 0.030 |
Why?
|
Allied Health Personnel | 1 | 2015 | 156 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12963 | 0.030 |
Why?
|
Prospective Studies | 2 | 2015 | 54190 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12793 | 0.030 |
Why?
|
Hotlines | 1 | 2013 | 55 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 982 | 0.030 |
Why?
|
Physician-Patient Relations | 2 | 2017 | 3235 | 0.030 |
Why?
|
Communication | 2 | 2017 | 3846 | 0.030 |
Why?
|
United Nations | 1 | 2013 | 152 | 0.030 |
Why?
|
Salaries and Fringe Benefits | 1 | 2015 | 256 | 0.030 |
Why?
|
Telemedicine | 1 | 2010 | 2997 | 0.030 |
Why?
|
Waiting Lists | 1 | 2017 | 749 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2698 | 0.030 |
Why?
|
Residence Characteristics | 2 | 2014 | 2035 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22023 | 0.030 |
Why?
|
Logistic Models | 3 | 2013 | 13309 | 0.030 |
Why?
|
Workflow | 1 | 2017 | 850 | 0.030 |
Why?
|
Diagnosis-Related Groups | 1 | 2014 | 450 | 0.030 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2017 | 421 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14648 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11891 | 0.020 |
Why?
|
Data Collection | 1 | 2021 | 3317 | 0.020 |
Why?
|
Appointments and Schedules | 1 | 2015 | 437 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2016 | 782 | 0.020 |
Why?
|
Glomerulonephritis | 1 | 2013 | 334 | 0.020 |
Why?
|
Geography | 1 | 2013 | 661 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4893 | 0.020 |
Why?
|
Disasters | 1 | 2017 | 511 | 0.020 |
Why?
|
Insulin | 1 | 2005 | 6589 | 0.020 |
Why?
|
Stroke | 1 | 2013 | 9936 | 0.020 |
Why?
|
Sex Factors | 2 | 2016 | 10515 | 0.020 |
Why?
|
Morbidity | 1 | 2016 | 1763 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3719 | 0.020 |
Why?
|
Community-Institutional Relations | 1 | 2011 | 207 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2017 | 2649 | 0.020 |
Why?
|
Biomedical Research | 1 | 2005 | 3414 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2005 | 18937 | 0.020 |
Why?
|
Refugees | 1 | 2017 | 594 | 0.020 |
Why?
|
Workplace | 1 | 2015 | 854 | 0.020 |
Why?
|
Legislation, Drug | 1 | 2010 | 213 | 0.020 |
Why?
|
Comorbidity | 2 | 2013 | 10550 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 2393 | 0.020 |
Why?
|
Aerosols | 1 | 2010 | 633 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2013 | 571 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5499 | 0.020 |
Why?
|
Rural Population | 1 | 2018 | 2260 | 0.020 |
Why?
|
Learning | 1 | 2017 | 1729 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3460 | 0.020 |
Why?
|
Child Health Services | 1 | 2013 | 644 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10825 | 0.020 |
Why?
|
Burnout, Professional | 1 | 2015 | 699 | 0.020 |
Why?
|
India | 1 | 2013 | 2344 | 0.020 |
Why?
|
Diabetes Mellitus | 2 | 2016 | 5875 | 0.020 |
Why?
|
Patient Readmission | 1 | 2021 | 3323 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5067 | 0.020 |
Why?
|
Dumping Syndrome | 1 | 2005 | 18 | 0.020 |
Why?
|
Diazoxide | 1 | 2005 | 52 | 0.020 |
Why?
|
Nurses | 1 | 2015 | 2466 | 0.020 |
Why?
|
Markov Chains | 1 | 2009 | 972 | 0.020 |
Why?
|
Nicotine | 1 | 2010 | 677 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2009 | 1599 | 0.020 |
Why?
|
Drug Costs | 1 | 2013 | 1183 | 0.020 |
Why?
|
Octreotide | 1 | 2005 | 152 | 0.020 |
Why?
|
Decision Making | 1 | 2018 | 3917 | 0.010 |
Why?
|
Diet Therapy | 1 | 2005 | 151 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39213 | 0.010 |
Why?
|
Child | 3 | 2021 | 79604 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 2011 | 1722 | 0.010 |
Why?
|
Incidence | 2 | 2013 | 21344 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2010 | 1719 | 0.010 |
Why?
|
Mental Health | 1 | 2017 | 3195 | 0.010 |
Why?
|
World Health Organization | 1 | 2009 | 1317 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9274 | 0.010 |
Why?
|
Longevity | 1 | 2010 | 1046 | 0.010 |
Why?
|
Hyperplasia | 1 | 2005 | 1157 | 0.010 |
Why?
|
Diarrhea | 1 | 2009 | 1340 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2010 | 1676 | 0.010 |
Why?
|
Infant | 2 | 2015 | 35940 | 0.010 |
Why?
|
Computer Simulation | 1 | 2015 | 6195 | 0.010 |
Why?
|
Nursing Homes | 1 | 2009 | 1072 | 0.010 |
Why?
|
Child, Preschool | 2 | 2015 | 41932 | 0.010 |
Why?
|
Pancreatectomy | 1 | 2005 | 809 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5192 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10181 | 0.010 |
Why?
|
Efferent Pathways | 1 | 2000 | 165 | 0.010 |
Why?
|
Sternum | 1 | 2000 | 175 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 2218 | 0.010 |
Why?
|
Pancreas | 1 | 2005 | 1674 | 0.010 |
Why?
|
Cholera Toxin | 1 | 2000 | 559 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2000 | 2262 | 0.010 |
Why?
|
Dogs | 1 | 2000 | 3839 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2000 | 1975 | 0.010 |
Why?
|
Societies, Medical | 1 | 2005 | 3890 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26099 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7379 | 0.010 |
Why?
|
Hospitalization | 1 | 2009 | 10732 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11046 | 0.000 |
Why?
|
Animals | 1 | 2000 | 167531 | 0.000 |
Why?
|